Growing new breed of vaccine-producing plants to fight human diseases worldwide

July 24, 2004

LAKE BUENA VISTA, FLORIDA -- At his presentation at the annual meeting of the American Society of Plant Biologists (ASPB) here July 24, 2004, Arizona State University Professor Charles J. Arntzen explained the newest advances in his research on plant-producing vaccines.

The development and introduction of new vaccines to improve global public health faces many challenges, Arntzen noted. The vaccines must address the need for lower costs, oral-administration (needle-free), heat stability, and they must include combination vaccines including those that protect against diseases that occur predominantly in developing countries, he added.

Over the last decade, the team working with Arntzen has shown that a set of genes from human pathogens can be introduced into plant cells, and intact plants regenerated which "bio-manufacture" subunit vaccines consisting of the pathogen gene products. Simple feeding of the plant tissues to animals or humans results in an immune response to the subunit vaccines," Arntzen commented.

Arntzen's research focuses now on producing vaccines in tomatoes to fight human afflictions such as cholera, Norwalk Virus and hepatitis B. Norwalk Virus is a major cause of gastrointestinal infection and diarrhea. Diarrheal diseases kill at least two million people in the world each year, most of them children, Arntzen noted.

Ongoing research is focused on development of minimal processing technology, adopted from the food industry, to yield uniform doses of heat-stable vaccine for oral delivery, Arntzen said. He provided a summary on the strategies used to ensure that plants used in vaccine manufacture will not be mixed with those used in the food chain, and on the rationale for adoption of plant-derived vaccine technology in developing countries.

Arntzen was appointed the Florence Ely Nelson Presidential Endowed Chair at Arizona State University in Tempe in 2000. He served as the Founding Director of the Arizona Biodesign Institute until May 2003. He currently serves as the Co-Director of the Center for Infectious Diseases and Vaccinology of that Institute, with Professor Roy Curtiss. Arntzen was elected to the U.S. National Academy of Sciences in 1983 and to the National Academy of Sciences in India the following year. He has served since 2001 on the President's Council of Advisors on Science and Technology (PCAST) of President George W. Bush.

Immediately before his talk 6:30 p.m. today, Arntzen received the American Society of Plant Biologists 2004 Leadership in Science Public Service Award. The award is presented to an individual who has made outstanding contributions to science and society.

Past years recipients of the ASPB Leadership in Science Public Service Award are Alexander von Humboldt Award for Agriculture winner Dr. Dennis Gonsalves, Nobel Laureate for Peace Dr. Norman Borlaug, Dr. Ingo Potrykus, whose discoveries produced Golden Rice to combat human blindness and other afflictions, Rockefeller Foundation President Dr. Gordon Conway, and U.S. Senator Christopher Bond (R-MO).
-end-
The American Society of Plant Biologists, founded in 1924, is a non-profit society of nearly 6,000 plant scientists from the United States and 60 other nations. The Society's annual meeting here at Disney's Coronado Springs Resort & Convention Center near Orlando, Florida attracted more than 1,200 scientists in attendance. ASPB publishes two of the most frequently cited plant science journals in the world: The Plant Cell and Plant Physiology.

Presenter: Charles Arntzen charles.arntzen@asu.edu phone: 480-727-7322

American Society of Plant Biologists

Related Infectious Diseases Articles from Brightsurf:

Understanding the spread of infectious diseases
Physicists at M√ľnster University (Germany) have shown in model simulations that the COVID-19 infection rates decrease significantly through social distancing.

Forecasting elections with a model of infectious diseases
Election forecasting is an innately challenging endeavor, with results that can be difficult to interpret and may leave many questions unanswered after close races unfold.

COVID-19 a reminder of the challenge of emerging infectious diseases
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).

Certain antidepressants could provide treatment for multiple infectious diseases
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.

Opioid epidemic is increasing rates of some infectious diseases
The US faces a public health crisis as the opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

Infectious diseases could be diagnosed with smartphones in sub-Saharan Africa
A new Imperial-led review has outlined how health workers could use existing phones to predict and curb the spread of infectious diseases.

The Lancet Infectious Diseases: Experts warn of a surge in vector-borne diseases as humanitarian crisis in Venezuela worsens
The ongoing humanitarian crisis in Venezuela is accelerating the re-emergence of vector-borne diseases such as malaria, Chagas disease, dengue, and Zika virus, and threatens to jeopardize public health gains in the country over the past two decades, warn leading public health experts.

Glow-in-the-dark paper as a rapid test for infectious diseases
Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

Math shows how human behavior spreads infectious diseases
Mathematics can help public health workers better understand and influence human behaviors that lead to the spread of infectious disease, according to a study from the University of Waterloo.

Many Americans say infectious and emerging diseases in other countries will threaten the US
An overwhelming majority of Americans (95%) think infectious and emerging diseases facing other countries will pose a 'major' or 'minor' threat to the U.S. in the next few years, but more than half (61%) say they are confident the federal government can prevent a major infectious disease outbreak in the US, according to a new national public opinion survey commissioned by Research!America and the American Society for Microbiology.

Read More: Infectious Diseases News and Infectious Diseases Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.